DK4021929T3 - hAM15-52-analoger med forbedret amylinreceptor (hAMY3R)-potens - Google Patents

hAM15-52-analoger med forbedret amylinreceptor (hAMY3R)-potens Download PDF

Info

Publication number: DK4021929T3
Authority: DK; Denmark
Prior art keywords: hamy3r; ham15; potency; analogs; amylin receptor
Prior art date: 2020-09-24

Application number

DK21782735.1T

Other languages

English (en)

Other versions

DK4021929T5 (da

Inventor

Kristoffer Tobias Gustav Rigbolt

Esben Matzen Bech

Morten Lundh

Paola Magotti

Niels Vrang

Jens Christian Frøslev Nielsen

Borja Ballarín-Gonzáles

Søren Ljungberg Pedersen

Original Assignee

Gubra As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-09-24

Filing date

2021-09-23

Publication date

2023-07-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=72659001&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4021929(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2021-09-23 Application filed by Gubra As filed Critical Gubra As

2023-07-10 Application granted granted Critical

2023-07-10 Publication of DK4021929T3 publication Critical patent/DK4021929T3/da

2023-07-17 Publication of DK4021929T5 publication Critical patent/DK4021929T5/da

Links

108091005466 amylin receptors Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Diabetes (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK21782735.1T 2020-09-24 2021-09-23 hAM15-52-analoger med forbedret amylinreceptor (hAMY3R)-potens DK4021929T5 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP20198117		2020-09-24
PCT/EP2021/076250 WO2022063925A1 (en)	2020-09-24	2021-09-23	Ham15-52 analogues with improved amylin receptor (hamy3r) potency

Publications (2)

Publication Number	Publication Date
DK4021929T3 true DK4021929T3 (da)	2023-07-10
DK4021929T5 DK4021929T5 (da)	2023-07-17

Family

ID=72659001

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK21782735.1T DK4021929T5 (da)	2020-09-24	2021-09-23	hAM15-52-analoger med forbedret amylinreceptor (hAMY3R)-potens

Country Status (21)

Country	Link
US (1)	US20240101634A1 (da)
EP (1)	EP4021929B1 (da)
JP (1)	JP2023544959A (da)
KR (1)	KR20230073176A (da)
CN (1)	CN116322741A (da)
AU (1)	AU2021350396A1 (da)
BR (1)	BR112023002525A2 (da)
CA (1)	CA3189267A1 (da)
DK (1)	DK4021929T5 (da)
ES (1)	ES2950137T3 (da)
FI (1)	FI4021929T3 (da)
HR (1)	HRP20230534T1 (da)
HU (1)	HUE062560T2 (da)
IL (1)	IL300620A (da)
MX (1)	MX2023002182A (da)
PL (1)	PL4021929T3 (da)
PT (1)	PT4021929T (da)
RS (1)	RS64256B1 (da)
SI (1)	SI4021929T1 (da)
WO (1)	WO2022063925A1 (da)
ZA (1)	ZA202301635B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2024003359A1 (en)	2022-07-01	2024-01-04	Gubra A/S	AMYLIN RECEPTOR (hAMY3R) AGONISTS WITH IMPROVED CHEMICAL STABILITY

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2330124B1 (en) *	2005-08-11	2015-02-25	Amylin Pharmaceuticals, LLC	Hybrid polypeptides with selectable properties
US8575090B2 (en)	2011-06-10	2013-11-05	Novo Nordisk A/S	Amylin analogues and pharmaceutical compositions thereof
AR097701A1 (es) *	2013-09-19	2016-04-13	Zealand Pharma As	Análogos de amilina
MX2017011182A (es)	2015-03-18	2018-06-06	Zealand Pharma As	Analogos de amilina.
EP3645031A4 (en)	2017-06-30	2021-03-31	Adepthera LLC	PEPTIDIC ANALOGUES
WO2020077129A1 (en) *	2018-10-11	2020-04-16	Intarcia Therapeutics, Inc.	Human amylin analog polypeptides and methods of use

2021
- 2021-09-23 BR BR112023002525A patent/BR112023002525A2/pt unknown
- 2021-09-23 CA CA3189267A patent/CA3189267A1/en active Pending
- 2021-09-23 CN CN202180056599.9A patent/CN116322741A/zh active Pending
- 2021-09-23 PL PL21782735.1T patent/PL4021929T3/pl unknown
- 2021-09-23 PT PT217827351T patent/PT4021929T/pt unknown
- 2021-09-23 ES ES21782735T patent/ES2950137T3/es active Active
- 2021-09-23 AU AU2021350396A patent/AU2021350396A1/en active Pending
- 2021-09-23 MX MX2023002182A patent/MX2023002182A/es unknown
- 2021-09-23 FI FIEP21782735.1T patent/FI4021929T3/fi active
- 2021-09-23 SI SI202130047T patent/SI4021929T1/sl unknown
- 2021-09-23 IL IL300620A patent/IL300620A/en unknown
- 2021-09-23 HU HUE21782735A patent/HUE062560T2/hu unknown
- 2021-09-23 RS RS20230442A patent/RS64256B1/sr unknown
- 2021-09-23 KR KR1020237005061A patent/KR20230073176A/ko unknown
- 2021-09-23 WO PCT/EP2021/076250 patent/WO2022063925A1/en active Search and Examination
- 2021-09-23 EP EP21782735.1A patent/EP4021929B1/en active Active
- 2021-09-23 HR HRP20230534TT patent/HRP20230534T1/hr unknown
- 2021-09-23 US US18/024,879 patent/US20240101634A1/en active Pending
- 2021-09-23 DK DK21782735.1T patent/DK4021929T5/da active
- 2021-09-23 JP JP2023510390A patent/JP2023544959A/ja active Pending
2023
- 2023-02-09 ZA ZA2023/01635A patent/ZA202301635B/en unknown

Also Published As

Publication number	Publication date
HUE062560T2 (hu)	2023-11-28
FI4021929T3 (fi)	2023-06-14
EP4021929A1 (en)	2022-07-06
RS64256B1 (sr)	2023-07-31
PL4021929T3 (pl)	2023-07-31
SI4021929T1 (sl)	2023-09-29
MX2023002182A (es)	2023-11-16
AU2021350396A1 (en)	2023-03-16
CA3189267A1 (en)	2022-03-31
ZA202301635B (en)	2024-03-27
JP2023544959A (ja)	2023-10-26
DK4021929T5 (da)	2023-07-17
KR20230073176A (ko)	2023-05-25
CN116322741A (zh)	2023-06-23
PT4021929T (pt)	2023-06-21
EP4021929B1 (en)	2023-04-26
IL300620A (en)	2023-04-01
HRP20230534T1 (hr)	2023-08-04
BR112023002525A2 (pt)	2023-04-04
ES2950137T3 (es)	2023-10-05
WO2022063925A1 (en)	2022-03-31
US20240101634A1 (en)	2024-03-28

Publication	Publication Date	Title
DK3953327T3 (da)	2024-02-05	Melanocortin-4-receptor-agonister
DE112021004156A5 (de)	2023-08-10	Luftfahrzeug
DK3433249T3 (da)	2023-02-13	Blokering af toll-lignende receptor 9 signalering med en lille molekyleantagonist
DK3762380T3 (da)	2022-01-17	Phenylpyrrolidinon-formylpeptid-2-receptoragonister
DK4122954T3 (da)	2024-06-10	Novel GLP-1-analoger
DK4021929T5 (da)	2023-07-17	hAM15-52-analoger med forbedret amylinreceptor (hAMY3R)-potens
MA54545A (fr)	2021-10-27	Analogues de rifamycine et conjugués anticorps-médicament de ceux-ci
DK3661941T3 (da)	2023-03-13	Thiazolopyridinderivater som adenosinreceptor-antagonister
DK3886813T3 (da)	2023-05-01	Farmaceutiske formuleringer af cyclosporinanaloger
IL283673A (en)	2021-07-29	Deuterated acetyl-leucine analogs
GB201816639D0 (en)	2018-11-28	GLP-1 Receptor Antagonist
ES2974824T3 (es)	2024-07-01	Potenciadores del receptor de AMPA
ES1277256Y (es)	2021-12-03	Estacion de preparacion de pedidos
ES1279955Y (es)	2022-01-18	Estructura de ecosondeos
ES2975595T3 (es)	2024-07-09	Chupete
ZA202006370B (en)	2021-07-28	Deuterated analogs of elacridar
DK3729079T3 (da)	2022-05-23	Potensassay af sekretomer
ES1301316Y (es)	2023-09-20	Chupete
JP1748205S (ja)	2023-07-07	おしゃぶり
IL310696A (en)	2024-04-01	Lymphocyte intensity test
ES1290245Y (es)	2022-08-01	Estacion de preparacion de pedidos
ES1232994Y (es)	2019-10-21	Depurador atmosférico
JP1723743S (ja)	2022-09-01	おしゃぶり
GB202110229D0 (en)	2021-09-01	Carnosine Analogs
ES1257590Y (es)	2021-02-23	Prendas con elementos de iluminacion